# A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer

> **NCT07227831** · NA · NOT_YET_RECRUITING · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 82 (estimated)

## Conditions studied

- HER2-negative Breast Cancer
- Hormone Receptor Positive Tumor
- Advanced Breast Cancer
- Metastatic Breast Cancer

## Interventions

- **DEVICE:** TheraBionic P1

## Key facts

- **NCT ID:** NCT07227831
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2027-05-22
- **Final completion:** 2028-05-22
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2025-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07227831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07227831, "A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07227831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*